Spectromics develops a diagnostic system that helps to guide antibiotic treatment. It provides a point-of-prescription test for bacterial infections that guides the treatment of antibiotics.
Spectromics began operation in 2014. Its headquarters is in Manchester in the United Kingdom.
Exosect Limited, established in 2001 as a spin-out from the University of Southampton, specializes in developing innovative platforms that enhance the delivery of biological and synthetic active ingredients for pesticide manufacturers. The company's proprietary technologies, including the Entostat and Entomag delivery platforms, address challenges such as pest resistance, regulatory compliance, and food safety residues. The Entostat platform utilizes an electrostatically charged micro powder for microencapsulation and controlled release of active ingredients, while the Entomag platform employs ferrous micro powder for targeted delivery, particularly against crawling insects in public health applications. With a robust portfolio of 41 patents and 28 national product registrations, Exosect is strategically positioned to commercialize its patented technologies across agriculture, public health, and animal health sectors, aiming to improve pest control and food protection. The company is headquartered in Winchester, United Kingdom.
Arago’s technology is a platform technology which has been exemplified in its first product offering which is an electrically insulating composite cross-arm for transmission towers. This approach allows tower voltages to be increased without any change to the overall profile of the tower structure or height. It is hoped that rolling out the technology will enable National Grid and other global transmission companies to begin to meet the 50% increase* in electrical energy that is anticipated to flow through the electricity system to facilitate the decarbonisation of energy and the introduction of electric vehicles/heat pumps by 2050.
PowerOasis Limited is a UK-based company that specializes in energy and critical infrastructure management solutions designed to enhance energy efficiency and infrastructure resilience. The company offers an Energy Management Platform, a comprehensive software suite that facilitates the Internet of Energy by enabling control, monitoring, and management of diverse energy generation, storage, and efficiency assets. This platform is customizable to meet the specific requirements of various licensees, including battery vendors and utilities. Additionally, PowerOasis develops and manufactures hybrid power systems, including a hybrid control cabinet, SolarCompact, and PowerCube, which integrate energy generation and storage solutions. The company's technology serves a wide range of sectors, including energy storage, transportation, oil and gas, and critical infrastructure, and it has established a presence in South East Asia, Africa, the Middle East, and North America. Founded in 2006 and headquartered in Swindon, PowerOasis aims to empower organizations to optimize their energy operations effectively.
Oxford Photovoltaics Limited develops and commercializes thin-film perovskite solar cells that are printed directly onto silicon solar cells, CIGS solar cells, or glass. Oxford Photovoltaics Limited has a strategic partnership with Meyer Burger Technology Ltd. The company was incorporated in 2010 and is based in Oxford, United Kingdom.
Renephra Ltd is a medical device company developing a groundbreaking Transdermal Fluid Removal (TFR) technology for minimally invasive fluid removal.
We are targeting the significant problems of fluid overload and chronic oedema / lymphoedema in vascular, oncology and other disease areas.
This is a substantial patient group with unmet clinical needs and is an estimated £1billion market worldwide.
Having achieved proof of concept in humans, Renephra is raising £400k to conduct device development study and design feasability.
Cable-Sense Ltd is a company based in Lancaster, United Kingdom, that specializes in network cabling infrastructure services. Founded in 2004, Cable-Sense offers advanced technology for monitoring, scanning, and mapping network cables, as well as providing services related to network security, audits, and management. The company aims to enhance the efficiency of businesses' cabling infrastructure, making existing Intelligent Infrastructure Management solutions more accessible and cost-effective. By delivering extensive functionality, Cable-Sense helps organizations achieve significant savings in material, energy, and operational costs associated with their cabling networks.
BiOxyDyn is a company specialising in the development and application of new diagnostic imaging tools and imaging services. Their portfolio of technologies and capabilities includes imaging tools to improve the understanding of lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma. They are also active in the development of new imaging tools for oncology and neuroscience.
Arvia Technology Limited specializes in advanced water and wastewater treatment systems, focusing on the removal of hazardous organic chemicals from water. The company's flagship product, the Organics Destruction Cell (ODC), integrates adsorption with advanced oxidation in a single, scalable unit. This innovative technology uses a patented regenerating adsorbent known as Nyex, which concentrates contaminants for targeted and continuous oxidation, allowing the system to operate without interruption or the need for replacement media. Arvia's process effectively reduces hard chemical oxygen demand, color, and persistent organic micro-pollutants, ensuring compliance with local wastewater discharge regulations and facilitating water reuse. The company serves various industries, including chemicals, food and beverage, nuclear, pharmaceuticals, and utilities. Founded in 2007 and based in Runcorn, United Kingdom, Arvia was previously known as Electroclean Technology Limited until its name change in 2008.
Ai2 Ltd is a biotechnology company based in Manchester, United Kingdom, established in 2004. The company specializes in the development of anti-infective peptide technology derived from the amino acid sequence of human protein Apo lipoprotein E. These peptides demonstrate broad-spectrum efficacy against various pathogens, including Gram-positive and Gram-negative bacteria, fungi, and viruses, including resistant strains. Ai2's technology has diverse applications in healthcare and personal care, encompassing ophthalmic products, oral care, advanced wound care, and medical devices. The company produces coated hydrogels, artificial joints, endotracheal tubes, wound dressings, and urinary and vascular catheters designed to prevent microbial colonization and contamination. Ai2 serves healthcare companies primarily in the United States and Europe, enabling medical practitioners to utilize its innovative technology across multiple applications.
PowerOasis Limited is a UK-based company that specializes in energy and critical infrastructure management solutions designed to enhance energy efficiency and infrastructure resilience. The company offers an Energy Management Platform, a comprehensive software suite that facilitates the Internet of Energy by enabling control, monitoring, and management of diverse energy generation, storage, and efficiency assets. This platform is customizable to meet the specific requirements of various licensees, including battery vendors and utilities. Additionally, PowerOasis develops and manufactures hybrid power systems, including a hybrid control cabinet, SolarCompact, and PowerCube, which integrate energy generation and storage solutions. The company's technology serves a wide range of sectors, including energy storage, transportation, oil and gas, and critical infrastructure, and it has established a presence in South East Asia, Africa, the Middle East, and North America. Founded in 2006 and headquartered in Swindon, PowerOasis aims to empower organizations to optimize their energy operations effectively.
Exosect Limited, established in 2001 as a spin-out from the University of Southampton, specializes in developing innovative platforms that enhance the delivery of biological and synthetic active ingredients for pesticide manufacturers. The company's proprietary technologies, including the Entostat and Entomag delivery platforms, address challenges such as pest resistance, regulatory compliance, and food safety residues. The Entostat platform utilizes an electrostatically charged micro powder for microencapsulation and controlled release of active ingredients, while the Entomag platform employs ferrous micro powder for targeted delivery, particularly against crawling insects in public health applications. With a robust portfolio of 41 patents and 28 national product registrations, Exosect is strategically positioned to commercialize its patented technologies across agriculture, public health, and animal health sectors, aiming to improve pest control and food protection. The company is headquartered in Winchester, United Kingdom.
Oxford Photovoltaics Limited develops and commercializes thin-film perovskite solar cells that are printed directly onto silicon solar cells, CIGS solar cells, or glass. Oxford Photovoltaics Limited has a strategic partnership with Meyer Burger Technology Ltd. The company was incorporated in 2010 and is based in Oxford, United Kingdom.
Eykona Medical develops and markets portable three dimensional imaging systems. Its systems are used to capture environments for videogames and in medical imaging for dermatological care. The company is based in Oxford, the United Kingdom.
BiOxyDyn is a company specialising in the development and application of new diagnostic imaging tools and imaging services. Their portfolio of technologies and capabilities includes imaging tools to improve the understanding of lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma. They are also active in the development of new imaging tools for oncology and neuroscience.
Ai2 Ltd is a biotechnology company based in Manchester, United Kingdom, established in 2004. The company specializes in the development of anti-infective peptide technology derived from the amino acid sequence of human protein Apo lipoprotein E. These peptides demonstrate broad-spectrum efficacy against various pathogens, including Gram-positive and Gram-negative bacteria, fungi, and viruses, including resistant strains. Ai2's technology has diverse applications in healthcare and personal care, encompassing ophthalmic products, oral care, advanced wound care, and medical devices. The company produces coated hydrogels, artificial joints, endotracheal tubes, wound dressings, and urinary and vascular catheters designed to prevent microbial colonization and contamination. Ai2 serves healthcare companies primarily in the United States and Europe, enabling medical practitioners to utilize its innovative technology across multiple applications.
Exosect Limited, established in 2001 as a spin-out from the University of Southampton, specializes in developing innovative platforms that enhance the delivery of biological and synthetic active ingredients for pesticide manufacturers. The company's proprietary technologies, including the Entostat and Entomag delivery platforms, address challenges such as pest resistance, regulatory compliance, and food safety residues. The Entostat platform utilizes an electrostatically charged micro powder for microencapsulation and controlled release of active ingredients, while the Entomag platform employs ferrous micro powder for targeted delivery, particularly against crawling insects in public health applications. With a robust portfolio of 41 patents and 28 national product registrations, Exosect is strategically positioned to commercialize its patented technologies across agriculture, public health, and animal health sectors, aiming to improve pest control and food protection. The company is headquartered in Winchester, United Kingdom.
Nano ePrint, Ltd. develops electronic devices. Its products are used in printed and plastic electronics applications, including radio-frequency identification, sensors, and display backplanes. The company also provides intellectual property licences, as well as research, development, and supply chain support services. Nano ePrint, Ltd., formerly known as Plastic ePrint Limited, was founded in 2006. The company is based in Manchester, the United Kingdom.
Lein Applied Diagnostics Ltd. specializes in developing advanced measurement devices and solutions for both healthcare and industrial applications. Founded in 2003 and based in Reading, United Kingdom, the company has established itself as a leader in optical metrology. Its product lineup includes the Dione source/detector module for multi-layer thickness measurements, the compact Icon optical measurement system, the fScan non-contact 3D fluorescence tracking plate reader, and the CTS2 thickness measurement system for engineered tissues and cells. These innovations serve various applications, including metrology, pharmacokinetics, and diabetes care. Lein's core technology is centered around a scanning confocal system that enables precise, non-contact measurements of both organic and man-made materials. The company distributes its products through agents in key markets such as China, Japan, and North America.
Datalase Ltd. specializes in developing materials for laser coding and marking across various industries, including pharmaceuticals, food and beverage, electronics, cosmetics, and tobacco. The company's innovative ink solutions enable high-speed, in-line digital printing, allowing for the customization of packaging with variable information such as date and lot codes, barcodes, and graphics. Datalase's proprietary technology is designed for use on outercases, products, and primary packaging, enhancing quality and operational efficiency for brand owners. The company operates through a partner network in Europe, the United States, and Asia, and has established strategic partnerships with key industry players. Founded in 1987 and based in Widnes, United Kingdom, Datalase was previously known as Sherwood Technology Ltd. before rebranding in 2006.
Eleksen Group Plc
Venture Round in 2006
Eleksen Group designs and develops fabric touchpads for use in human machine interface design using its ElekTex technology. The company licenses ElekTex and reference design to manufacturers for use in custom electronics design, as well as markets a range of ready-to-integrate solutions for garment, bags, and accessories manufacturers. It offers sensors for use in soft-goods products, such as apparel and accessory products, as well as in other applications to provide control interfaces.
Global Silicon
Series B in 2005
Global Silicon Limited, a fabless semiconductor company, engages in the design, development, and manufacture of proprietary mixed signal chips for the consumer audio market. It offers CD servo controllers and high performance MP3 and windows media audio (WMA) decoders. The company also offers PCB modules, design wins, and xin servo/mp3/wma. Global Silicon Limited was formerly known as Cheap and Cheerful Chip Company Limited. The company was incorporated in 1997 and is based in Marlow, the United Kingdom with additional offices in Fenggang, Swavesey, and Cambridge, as well as in Shenzhen, the People's Republic of China. Global Silicon Limited is in receivership.
Medisyn Technologies, Inc., a biotechnology company, develops pre-qualified proprietary drug compounds. Its Forward Engineering platform is used for producing compounds for breast, renal, prostate, and lung-cancer treatments. The company also analyzes and optimizes existing drugs, and develops new drug candidates for its partners. In addition, it offers testing and analysis services to predict safety and efficacy of compounds. The company serves biotech and pharmaceutical companies. Medisyn Technologies, Inc. was founded in 1999 and is headquartered in Minnetonka, Minnesota.
Andritz Powerlase Ltd. designs and manufactures high power pulsed lasers for industrial applications that include materials processing. It offers infrared, green, and ultraviolet lasers for HSTB, surface polishing, rust removal, de-painting, cleaning, laser annealing, conservation, surface structuring, and CFRP applications. Andritz Powerlase Ltd. was formerly known as Powerlase Photonics Limited and changed its name to Andritz Powerlase Ltd. in June 2017. The company was founded in 2000 and is based in Crawley, United Kingdom. Andritz Powerlase operates as a subsidiary of Andritz AG.
Founded in 1998, they now have a team with over 200 man-years of embedded systems engineering expertise, with a solid background in the design of 32-bit RISC devices and systems. This includes expertise in real-time systems, VHDL and RTL coding, modeling, application code development in C and assembler languages, and tool development on both UNIX and PC platforms. The three founding members of Beach Solutions remain serving as executive board members of the company.
ApaTech Ltd., an ortho-biologics company, produces synthetic bone repair materials. It offers Actifuse, a synthetic bone graft, which creates a material that promotes the formation of bone and increases the volume of bone formed in the graft/host bone composite structures for small void filling and spinal fusion applications. The company also provides ApaPore, a synthetic and porous hydro-xyapatite grafting for the cemented revision of failed total joint arthroplasties for spinal fusions and fracture fixations, as well as for treating bone defects; and Actifuse MIS Bone Graft Delivery System that offers controlled delivery and precise placement for surgeons performing open and minimally invasive procedures, as well as for use in various spinal and orthopedic procedures, including posterolateral fusion, bone void filling, and acetabular cysts. It offers its products through distributors in the United Kingdom, Ireland, Norway, Sweden, Germany, Austria, Spain, Portugal, Italy, Greece, Turkey, Kuwait, Syria, Australia, and New Zealand. ApaTech Ltd. was founded in 2001 and is based in Elstree, the United Kingdom. It has operations in London, the United Kingdom; Foxborough, Massachusetts; and Berlin, Germany.
Sarantel is a leader in the design of high-performance miniature antennas for portable wireless applications. Sarantel’s revolutionary ceramic filtering antennas offer dramatically improved performance over existing antenna designs, resulting in a clearer signal, better range and a 90 per cent reduction in the amount of signal radiation absorbed by the body. Because of their smaller size and higher capabilities, Sarantel’s antennas enable manufacturers to create innovative wireless products for the GPS, Satellite Radio and Satellite phone markets.
DCT develops, licences and manufactures semiconductor IP, integrated circuits, software and development systems. Founded with personal investments from Turner & Kubiczek, it went on to win a Small Firms Merit Award for Research & Technology from the UK Department of Trade & Industry award for its novel and world-leading performance embedded Java CPU Lightfoot. Following the UK DTI investment, DCT closed two funding rounds with MTI, a global, early-stage Venture Capital investor and set up offices in California and Taiwan. DCT also developed the Bigfoot Java Accelerator IP that found application in video processor ICs. The company was incorporated in 1996 and is currently based in Egham, UK and Shanghai, China. It is presently developing an exciting new version of its Lightfoot architecture, LF v3, that will deliver new performance levels to resource-limited embedded ASSPs.
A provider of enterprise monitoring and data collection software